Global Remdesivir Market 2026–2035 supported by antiviral treatment demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Remdesivir Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The remdesivir market has experienced rapid expansion in recent times. This market is projected to expand from $8.52 billion in 2025 to reach $11.17 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 31.2%. Historically, this expansion was largely due to factors such as the emergency use authorization for remdesivir, elevated hospitalization figures during covid-19 surges, a scarcity of alternative antiviral treatments, increased understanding of antiviral therapies, and the swift establishment of hospital procurement networks.

The remdesivir market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $17.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is attributable to the creation of new remdesivir formulations, the rising adoption of oral and ready-to-use injectable solutions, the broader availability of telemedicine-assisted antiviral administration, increasing government efforts for covid-19 management, and the expansion of online pharmacy and home delivery services. Key trends expected throughout this period encompass a growing demand for intravenous antiviral therapies, enhanced uptake of oral antiviral formulations, an increase in hospitalizations and critical care treatments for covid-19, the broadening of online and retail pharmacy distribution networks, and the development of ready-to-use injectable and lyophilized powder solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp

What Drivers Are Influencing The Remdesivir Market?

The remdesivir market is anticipated to expand due to increasing government expenditure. Government expenditure, also known as public sector spending, represents the total funds a government or public entity dedicates and spends to finance its operations, programs, services, and projects. This spending plays a crucial role in enhancing the growth and accessibility of Remdesivir, particularly during health emergencies. Through funding, regulatory backing, purchasing power, and investments in research, governments are able to ensure the availability and affordability of this essential antiviral drug. For example, data from the American Medical Association, a US-based Professional organization, revealed that in 2023, U.S. health spending escalated by 7.5% to $4.9 trillion, equating to $14,570 per capita, which surpassed the 4.6% rise observed in 2022. Consequently, the rising government spending is fostering the expansion of the remdesivir market.

What Major Segment Divisions Exist Within The Remdesivir Market?

The remdesivir market covered in this report is segmented –

1) By Route Of Administration: Oral, Intravenous

2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution

3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels

Subsegments:

1) By Oral: Tablet Formulation, Liquid Formulation

2) By Intravenous: Ready-To-Use Injectable, Lyophilized Powder For Injection

Which Companies Are Leading Innovation In The Remdesivir Market?

Major companies operating in the remdesivir market are Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Dr Reddy’s Laboratories Ltd., Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories

Read the full remdesivir market report here:

https://www.thebusinessresearchcompany.com/report/remdesivir-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Remdesivir Market?

North America was the largest region in the remdesivir market in 2025. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in the remdesivir market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Remdesivir Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3253&type=smp

Browse Through More Reports Similar to the Global Remdesivir Market 2026, By The Business Research Company

Coronavirus Current Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

3D Cell Culture Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Consumables And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795